---
title: Sinopep-Allsino Biopharmaceutical Co., Ltd. vs Veranova
slug_a: sinopep
slug_b: veranova
site: cdmo
review_signal_gate: closed
canonical_path: /compare/sinopep/veranova
---

# Sinopep-Allsino Biopharmaceutical Co., Ltd. vs Veranova

Side-by-side profile data from each company listing on this directory.

## Sinopep-Allsino Biopharmaceutical Co., Ltd.

- Profile: [/companies/sinopep](/companies/sinopep)

Sinopep-Allsino Biopharmaceutical Co., Ltd. — GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.

Services: 6. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Oligonucleotide
- Peptide

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Veranova

- Profile: [/companies/veranova](/companies/veranova)

Veranova — Global CDMO specializing in development and manufacturing of complex active pharmaceutical ingredients (APIs), with expertise in solid form sciences, process development, and specialty modalities including ADCs and controlled substances.

Services: 13. Modalities: 4. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (13).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Solid-State Chemistry & Polymorph Screening
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- Peptide

### Development capabilities

- Analytical method development
- Formulation development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- HPAPI
- DEA licensed